Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3/2012

01.11.2012 | original article

Epidemiology and management of group B streptococcal colonization during pregnancy in Africa

verfasst von: M Capan, G Mombo-Ngoma, D Akerey-Diop, A Basra, H Würbel, W Lendamba, L Auer-Hackenberg, R Mackanga, J Melser, S Belard, Assoc. Prof. M Ramharter, MD

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Group B streptococcal infections are a leading cause of neonatal morbidity and mortality. Maternal microbiological screening during pregnancy and intrapartum antimicrobial treatment of maternal group B streptococcus (GBS) colonization constitutes an effective prevention strategy to reduce early neonatal invasive disease due to GBS in the European and North American setting. Data on the prevalence of GBS colonization in pregnancy and incidence of neonatal invasive GBS disease are very limited for low-income regions. However, the first reports from sub-Saharan Africa indicate that GBS colonization rates may be comparable to industrialized countries and that related neonatal morbidity and mortality is of significance. Prior to the development of suitable prevention strategies, which are undoubtedly needed in resource poor settings, more evidence on GBS epidemiology in sub-Saharan Africa and assessment of cost effectiveness of different prevention strategies are essential.
Literatur
2.
Zurück zum Zitat Kunze M, Ziegler A, Fluegge K, Hentschel R, Proempeler H, Berner R. Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single University Center in Germany. J Perinat Med. 2011;39(4):417–22.CrossRefPubMed Kunze M, Ziegler A, Fluegge K, Hentschel R, Proempeler H, Berner R. Colonization, serotypes and transmission rates of group B streptococci in pregnant women and their infants born at a single University Center in Germany. J Perinat Med. 2011;39(4):417–22.CrossRefPubMed
3.
Zurück zum Zitat Gray KJ, Bennett SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infections in infants, Malawi. Emerg Infect Dis. 2007;13(2):223–29.CrossRefPubMed Gray KJ, Bennett SL, French N, Phiri AJ, Graham SM. Invasive group B streptococcal infections in infants, Malawi. Emerg Infect Dis. 2007;13(2):223–29.CrossRefPubMed
4.
Zurück zum Zitat Cutland CL, Madhi SA, Zell ER, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009;374(9705):1909–16.CrossRefPubMed Cutland CL, Madhi SA, Zell ER, et al. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009;374(9705):1909–16.CrossRefPubMed
5.
Zurück zum Zitat López Sastre JB, Fernández Colomer B, Coto Cotallo GD, Ramos Aparicio A, Grupo deHospitales Castrillo. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr. 2005;94(4):451–7.CrossRefPubMed López Sastre JB, Fernández Colomer B, Coto Cotallo GD, Ramos Aparicio A, Grupo deHospitales Castrillo. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr. 2005;94(4):451–7.CrossRefPubMed
7.
Zurück zum Zitat Capan M, Mombo-Ngoma G, Makristathis A, Ramharter M. Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J. 2010;9:303.CrossRefPubMed Capan M, Mombo-Ngoma G, Makristathis A, Ramharter M. Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J. 2010;9:303.CrossRefPubMed
8.
Zurück zum Zitat Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 1998;17(6):499–503.CrossRefPubMed Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 1998;17(6):499–503.CrossRefPubMed
9.
Zurück zum Zitat Dzowela T, Komolafe OO, Igbigbi A. Prevalence of group B streptococcus colonization in antenatal women at the Queen Elizabeth Central Hospital, Blantyre—a preliminary study. Malawi Med J. 2005;17(3):97–9. Dzowela T, Komolafe OO, Igbigbi A. Prevalence of group B streptococcus colonization in antenatal women at the Queen Elizabeth Central Hospital, Blantyre—a preliminary study. Malawi Med J. 2005;17(3):97–9.
10.
Zurück zum Zitat Moyo R. Studies on streptococcus agalactiae surface anchored markers with emphasis on strains and human sera from Zimbabwe, in Norwegian University of Science and Technology. Norwegian University; 2002. pp. 45–8. Moyo R. Studies on streptococcus agalactiae surface anchored markers with emphasis on strains and human sera from Zimbabwe, in Norwegian University of Science and Technology. Norwegian University; 2002. pp. 45–8.
12.
Zurück zum Zitat Madhi SA, Radebe K, Crewe-Brown H, et al. High burden of invasive streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003;23(1):15–23.CrossRefPubMed Madhi SA, Radebe K, Crewe-Brown H, et al. High burden of invasive streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003;23(1):15–23.CrossRefPubMed
13.
Zurück zum Zitat Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One 2011;6(3):e17861.CrossRefPubMed Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One 2011;6(3):e17861.CrossRefPubMed
14.
Zurück zum Zitat Sigaúque B, Roca A, Mandomando I. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J. 2009;28(2):108–13.CrossRefPubMed Sigaúque B, Roca A, Mandomando I. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J. 2009;28(2):108–13.CrossRefPubMed
15.
Zurück zum Zitat Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect. 2011;17(9):1294–303.PubMed Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect. 2011;17(9):1294–303.PubMed
16.
Zurück zum Zitat Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010;39(Suppl 1):i102–9.CrossRefPubMed Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010;39(Suppl 1):i102–9.CrossRefPubMed
17.
Zurück zum Zitat Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics. 1981;68(4):544–9.PubMed Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics. 1981;68(4):544–9.PubMed
18.
Zurück zum Zitat Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999;179(1):142–50.CrossRefPubMed Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999;179(1):142–50.CrossRefPubMed
19.
Zurück zum Zitat Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996;98(10):2308–14.CrossRefPubMed Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996;98(10):2308–14.CrossRefPubMed
20.
Zurück zum Zitat Baker CJ, Paoletti LC, Rench MA, et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women. J Infect Dis. 2000;182(4):1129–38.CrossRefPubMed Baker CJ, Paoletti LC, Rench MA, et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women. J Infect Dis. 2000;182(4):1129–38.CrossRefPubMed
Metadaten
Titel
Epidemiology and management of group B streptococcal colonization during pregnancy in Africa
verfasst von
M Capan
G Mombo-Ngoma
D Akerey-Diop
A Basra
H Würbel
W Lendamba
L Auer-Hackenberg
R Mackanga
J Melser
S Belard
Assoc. Prof. M Ramharter, MD
Publikationsdatum
01.11.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 3/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0239-5

Weitere Artikel der Sonderheft 3/2012

Wiener klinische Wochenschrift 3/2012 Zur Ausgabe